Vicki Moore, PhD

Contributing Writer https://www.hematologyadvisor.com

Vicki Moore, PhD, is a freelance medical writer for Hematology Advisor. Vicki received her PhD in biology from Arizona State University, where her research emphasized molecular biology, biochemistry, and metabolic engineering. She also has experience with predictive analytics and is intrigued by its applications to medicine. Vicki has been a medical writer, focusing on areas of hematology and oncology, among other specialties, since late 2017. You can find her on Linkedin at linkedin.com/in/vicki-moore-93950913

All articles by Vicki Moore, PhD

Cryopreserved platelets may reduce bleeding in patients with thrombocytopenia.

General Hematology

Assay to Detect Antibodies to SARS-CoV-2 in Human Serum or Plasma

Vicki Moore, PhD

April 6, 2020

The researchers found that samples from patients with COVID-19 showed strong reactivity to both the full-length S protein and the RBD.

A nurse confers with a patient about upcoming treatment.

General Hematology

Fast-Track Clinic, Communications Reduce Infusion Clinic Wait Times

Vicki Moore, PhD

March 25, 2020

After identifying bottlenecks at a VA hospital infusion clinic in Alabama, better communications and establishing a fast-track clinic for some patients led to a 23% reduction in infusion clinic wait times.

CD33 positivity and MPC-1 negativity appear to be associated with worse outcomes in patients with multiple myeloma treated with bortezomib as induction therapy.

Lymphoma

Induction in Transplant-Eligible Mantle Cell Lymphoma With Rituximab and Cytarabine Added to Rituximab and Bendamustine

Vicki Moore, PhD

March 23, 2020

The researchers found that high rates of remission could be achieved with induction therapy using rituximab/bendamustine in addition to rituximab/cytarabine.

Lymphoma

Brentuximab Vedotin With Bendamustine for Patients With Refractory or Multiple Relapsed Classic Hodgkin Lymphoma

Vicki Moore, PhD

March 23, 2020

A retrospective analysis found encouraging evidence for the use of BvB in treatment of RR-cHL.

Anemia

Bleeding Incidences in Patients With Sickle Cell Disease

Vicki Moore, PhD

April 11, 2019

The authors included 6423 patients with SCD in what is believed to be the first study of the incidence of bleeding events in this patient population.

An illustration of a thrombosis forming.

Thrombotic Disorders

Deep Vein Thrombosis Incidence and Pulmonary Embolism Risk Stratification

Vicki Moore, PhD

March 20, 2020

High or intermediate PE risk status was linked with lower rates of DVT, but asymptomatic DVT was more often found with high or intermediate PE risk.

Men using portable spray rig on tree and grass environment.

General Hematology

Glyphosate Exposure and Relative Risks of Non-Hodgkin Lymphoma or Multiple Myeloma

Vicki Moore, PhD

March 19, 2020

Researchers conducted a meta-analysis of 7 studies involving NHL and 3 focused on MM to determine the role of occupational exposure to glyphosate in terms of risk.

General Hematology

Team-Based Approach Effective in Addressing Oncology Clinician Burnout

Vicki Moore, PhD

March 18, 2020

Preliminary results of a study on burnout among oncology clinicians, researchers report that a team-oriented program can be effective.

Bleeding Disorders

Von Willebrand Factor Plasma Levels and Risk for Major Adverse Cardiovascular Events

Vicki Moore, PhD

March 2, 2020

Patients who experienced major adverse cardiovascular events reported higher von Willebrand factor plasma levels compared with patients in the control cohort.